You have full text access to this OnlineOpen article

Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis

  1. J. OHATA1,2,4,
  2. J. SAKURAI1,
  3. K. SAITO1,
  4. K. TANI2,5,
  5. S. ASANO2,
  6. M. AZUMA1,3

Article first published online: 28 JUN 2002

DOI: 10.1046/j.1365-2249.2002.01857.x

Issue

Clinical & Experimental Immunology

Clinical & Experimental Immunology

Volume 129, Issue 1, pages 61–68, July 2002

Additional Information

How to Cite

OHATA, J., SAKURAI, J., SAITO, K., TANI, K., ASANO, S. and AZUMA, M. (2002), Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis. Clinical & Experimental Immunology, 129: 61–68. doi: 10.1046/j.1365-2249.2002.01857.x

Author Information

  1. 1

    Department of Immunology, National Children's Medical Research Center, Tokyo,

  2. 2

    Division of Molecular Therapy, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo,

  3. 3

    Department of Molecular Immunology, Division of Oral Health Sciences, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan. Present address:

  4. 4

    Division of Hematology/Oncology, University of California, San Diego, La Jolla, CA92093-0663, USA,

  5. 5

    Division of Molecular and Clinical Genetics, Department of Genetics, Hematology/Oncology, Medical Institute of Bioregulation, Kyushu University, Beppu, Oita 874-0838, Japan

* M. Azuma, Department of Molecular Immunology, Division of Oral Health Sciences, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113–8549, Japan. E-mail: miyuki.mim@tmd.ac.jp

Publication History

  1. Issue published online: 28 JUN 2002
  2. Article first published online: 28 JUN 2002

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (148K)

Keywords:

  •  co-stimulation GVL GVHD IL-12 tolerance

SUMMARY

Co-stimulatory blockade may be a promising strategy for tolerance induction in transplantation. In allogeneic bone marrow transplantation (BMT) for leukaemia treatment, however, preservation of the graft-versus-leukaemia (GVL) effect is another critical requirement for clinical application. In this study, we have compared the effect on GVL of using CD28 and CD40 co-stimulatory blockades as graft-versus-host disease (GVHD) prophylaxis in a murine allogeneic BMT model with simultaneous transfer of BCL1 leukaemia. Despite the relative improvement of GVHD as assessed by survival and body weight in both treatment regimes, treatment with anti-CD154 moAb clearly diminished the GVL effect, whereas treatment with anti-CD80 and CD86 MoAbs maintained this effect. Although T cell-mediated effector function at 14 days post-BMT assessed by IFNγ expression and cytotoxicity against host alloantigen was comparable between both co-stimulatory blockades, IL-12 mRNA expression was preferentially reduced by CD40 blockade. Our results suggest the differential involvement of the CD28 and CD40 co-stimulatory pathways in the development of GVHD and GVL effects. CD28 blockade may be a favourable strategy for tolerance induction in leukaemia patients undergoing BMT.

View Full Article (HTML) Get PDF (148K)